NCT02077543View on ClinicalTrials.gov

Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2020

Conditions
Glioma : Oligodendroglioma or Astrocytoma
Interventions
DEVICE

Brain Tissue Imprint - Medical Device (ProTool)

genomic, transcriptomic and proteomic studies.

Trial Locations (5)

38000

ACTIVE_NOT_RECRUITING

CLINATEC, Grenoble

RECRUITING

Grenoble University Hospital, Grenoble

75000

NOT_YET_RECRUITING

Sainte-Anne Hospital, Paris

Unknown

NOT_YET_RECRUITING

Angers University Hospital, Angers

NOT_YET_RECRUITING

Henri Mondor University Hospital, Créteil

Sponsors

Collaborators (1)

MEDIMPRINT
All Listed Sponsors
collaborator

MEDIMPRINT

UNKNOWN

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Grenoble

OTHER